Contact Grifols for inquiries and support. Our team is here to assist you with information and resources tailored to your needs.
If you bring something that someone wants or needs, you get it for them or carry it to them. He went and poured a brandy for Dena and brought it to her.
need (third-person singular simple present needs, present participle needing, simple past and past participle needed) (transitive) To have an absolute requirement for.
I need you. 例文帳に追加 君が必要だ。 - Tanaka Corpus I need one more. 例文帳に追加 もう1枚。 - 愛知県総合教育センター Classroom English（教室英語集） There need be no hurry, need there? 例文帳に追加 急ぐ必要はないでしょう. - 研究社 新英和中辞典 Do you need something? 例文帳 ...
「Why do you need that」のお隣キーワード Why do you need it so badly'? Why do you need me to take you? Why do you need my dna? Why do you need our victim's ear canal? oh, yes.
前置詞句 in need Lacking basic necessities such as food and shelter; poor; indigent. I donated the clothes my son outgrew to help children in need. In distress or otherwise difficult circumstances. a friend in need is a friend indeed The team came to the rescue of a whale in need. (when followed by “ of ”) Needing (the specified necessities). The house was in need of urgent repairs.
動詞 need to (third-person singular simple present needs to, present participle needing to, simple past and past participle needed to) Synonym of have to (“must”).
How YouTube search works YouTube has a tremendous amount of video content — over 500 hours are uploaded every minute! Without a robust search function, finding what you need would be nearly impossible. That's why YouTube’s search ranking system is designed to help you quickly find what you’re looking for. YouTube’s search ranking system
The 67th Allentown St. Patrick’s Day Parade was held Sunday. It featured 8 divisions, 10 pipe bands and more than 2,000 marchers. See photos below. People line the streets during the start of the St.
There is no automated way to add animated profile picture on Gmail. You’d first need to create the GIF by using online tools like remove.bg and Canva, and then upload that GIF as your profile picture ...
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Descubre las innovadoras soluciones biofarmacéuticas y sanitarias integrales de Grifols centradas en el paciente.
Explore Grifols Poland, a leader in biotechnology and healthcare, dedicated to improving patient lives through innovative therapies and high-quality services.
Grifols is a global healthcare company that has enhanced the health and well-being of people around the world.
Join Grifols to create a lasting impact with your career. Explore opportunities that allow you to contribute to life-saving solutions and innovate for a healthier future.
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ...
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the first analysis laboratory in Barcelona: Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos.
The sale of a minority stake of its U.S. Biopharma business by means of an initial public offering (IPO) would raise capital to strengthen the Group’s balance sheet, reduce debt and support investment in its strategic growth priorities, while allowing Grifols to maintain majority ownership of its U.S. Biopharma business The proposed transaction reinforces Grifols’ self-sufficiency vision ...
Explore Grifols France for cutting-edge pharmacovigilance and comprehensive medical information to enhance patient safety and treatment outcomes.
The Corner: Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Link Securities | Grifols (GRF) plans to make an early repayment of €500 million of its 7.5% senior secured bonds maturing in 2030. This transaction would ...
Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...
Yahoo Finance UK: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Recent performance context for Grifols Grifols (BME:GRF) has drawn investor attention after a mixed run, with a modest 1 day gain, a negative move over the past week and month, and a deeper decline ...
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
The Globe and Mail: Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Detailed price information for Grifols S.A. ADR (GRFS-Q) from The Globe and Mail including charting and trades.
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Yahoo Finance: Does Grifols (BME:GRF) Offer Opportunity After Sharp Share Price Declines And Debt Concerns
Does Grifols (BME:GRF) Offer Opportunity After Sharp Share Price Declines And Debt Concerns
Business Wire: Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman
Grifols’ admissions are the latest development since activist short seller Gotham City Research first took aim at the company on Jan. 9, 2024, releasing a scathing report attacking the company’s ...
Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman
MADRID (Reuters) -Spanish drugmaker Grifols has taken a 457 million euros ($494 million) writedown on its accounts for 2020 through 2023, to reflect what it says was a previously incorrect accounting ...
Seeking Alpha: Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
The addition of the Clayton site in 2011 marked a new milestone for Grifols (GRFS), turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The ...
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.